Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...
For many people who have bipolar I, lithium is that most elusive of pharmacological treatments, the “magic bullet”—a single intervention that completely eliminates the symptoms of a disease. Since the ...
Experts answer four key questions based on the findings of a study that indicated that low-dose oral lithium could slow ...
Dr McIntyre and colleagues share new insight on how GLP-1 receptor agonists may protect against lithium-induced kidney damage in patients treated for bipolar disorder.
When Lady Gaga recently spoke in an interview about taking lithium while suffering from a “psychotic break”, it drew ...
Changes Clinical Practice: Based on this large trial, lithium alone or a lithium-valproate combination should be used as first-line maintenance treatment for bipolar affective disorder type I instead ...
Researchers from the University of Adelaide are hopeful a recent biological discovery could lead to the precision treatment of bipolar disorder (BD). About 2.2% of the Australian population has a form ...
Lithium carbonate and valproate sodium are each recommended as monotherapy for preventing relapses in patients with bipolar disorder and are sometimes used in combination. However, combination therapy ...
A female patient in her 60s with bipolar disorder type 1 underwent robot-assisted radical cystectomy with ileal conduit for muscle-invasive bladder cancer. Postoperatively, she continued her regular ...
One woman spent years battling symptoms she couldn’t name—until a diagnosis and treatment finally brought clarity and renewed ...
Compared with lithium, valproate, olanzapine, quetiapine, and risperidone generally exhibited a lower likelihood of thyroid dysfunction. HealthDay News — Lithium is associated with an increased risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results